News
The Food and Drug Administration (FDA) is reportedly in discussions with OpenAI to expedite the drug approval process using ...
If it’s hard for allies to buy U.S. chips, they will get them from other suppliers—including the Chinese.
Some businesses enjoy too much growth momentum to be stopped by mere economic weakness or tariff-related turbulence.
Alibaba Group Holding (NYSE:BABA) fintech affiliate Ant Group explored listing its overseas arm, Ant International, on the ...
Although weaker US consumer sentiment presents a near-term headwind, Booking's leading network of hotel properties and other services, continues to expand in developed and emerging markets, as well as ...
Here Technologies, the world's leading digital map provider, is adapting its 40-year old service for a new age.
Huawei and Alibaba are outpacing established U.S. providers by aligning with government priorities and addressing data ...
Dinner conversations were dominated by DeepSeek and other A.I. chatbots. Electric cars whizzed by, and apps offered drone ...
Tariffs and geopolitics are the No. 1 concern among companies, and AI is being used to map supply chain locations and costs ...
Over the last few years, the S&P 500's returns have been driven by a handful of spectacular stocks benefiting from growing ...
We recently published an article titled Billionaire Ken Fisher’s 10 Technology Stock Picks with Huge Upside Potential. In ...
Nvidia is redesigning AI chips to comply with U.S. export rules while serving Chinese clients like Alibaba, ByteDance, and Tencent.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results